Importance of positron emission tomography-computed tomography (PET-CT) examination in rectal cancer staging - Initial clinical experience;Značaj pozitronske emisione tomografije-kompjuterizovane tomografije (PET-CT) u određivanju stadija karcinoma rektuma - Prvi klinički rezultati

Medicinski Glasnik

Volumn 10, Issue 2, 2013, Pages 304-308

  Ivanov, Olivera ^a   Ivanov, Dejan ^b   Mihailović, Jasna ^a   Erak, Marko ^b   Ivanov, Igor ^a   Basarić, Borko ^a  

^a Oncology Institute of Vojvodina ^*  (Serbia)

^b Scientific Veterinary Institute Novi Sad   (Serbia)

Author keywords

Histopathology; Imaging; Stage

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ADULT; ARTICLE; CANCER STAGING; CHEMORADIOTHERAPY; CLINICAL ARTICLE; COMORBIDITY; COMPUTER ASSISTED EMISSION TOMOGRAPHY; FEMALE; HISTOPATHOLOGY; HUMAN; MALE; PROSPECTIVE STUDY; QUALITY OF LIFE; RECTUM CANCER; SIMULATION; COMPUTER ASSISTED TOMOGRAPHY; POSITRON EMISSION TOMOGRAPHY;

HUMANS; NEOPLASM STAGING; POSITRON-EMISSION TOMOGRAPHY; PROSPECTIVE STUDIES; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84880714321     PISSN: 18400132     EISSN: 18402445     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Schiepers C. PET/CT in colorectal cancer. J Nucl Med 2003; 44:1804-5.
2. Hu H, Krasinkas A, Willis J. Perspectives on current tumor-node-metastasis (TNM) staging of cancers of the colon and rectum. Semin Oncol 2011; 38:500-10.
3. Mainenti PP, Iodice D, Segreto S, Storto G, Magliulo M, De Palma GD, Salvatore M, Pace L. Colorectal cancer and 18FDG-PET/CT: What about adding the T to the N parametar in locoregional staging? World J Gastroenterol 2011; 17:1427-33.
4. Cohade C, Osman M, Leal J, Wahl RL. Direct comparison of 18-F-FDG PET and PET/CT in patients with colorectal carcinoma. J Nucl Med 2003; 44:1797-803.
5. Kamel IR, Cohade C, Neyman E, Fishman EK, Wahl RL. Incremental value of CT in PET-CT of patients with colorectal carcinoma. Abdominal Imaging 2004; 29:663-8.
6. Moadel RM, Feng J, Freeman LM. PET-CT in the evaluation of colorectal carcinoma. Applied Radiology 2008; 7:33-42.
7. Gearhart SL, Frassica D, Rosen R, Choti M, Schulick R, Wahl R. Improved staging with pretreatment positron emission tomography-computed tomography in low rectal cancer. Annals of Surg Oncol 2006; 13:397-404.
8. Shin SS, Jeong YY, Min JJ, Kim HR, Chung TW, Kang HK. Preoperative staging of colorectal cancer: CT vs. integrated FDG PET-CT. Abdom Imaging 2008; 33:270-7.
9. Titu LV, Nicholson AA, Hartley JE, Breen DJ, Monson JRT. Routine follow-up by magnetic resonance imaging does not improve detection of resectable local recurrences from colorectal cancer. Ann Surg 2006; 243:348-52.
10. Eakin V, Foster R, Hann G, Hounnsel A, Lynch T, McAleese J. The role of PET-CT in radiotherapy planning. Imaging 2007; 6:13-15.
11. Janjan NA, Crane C, Feig BW, Karen C, Dubrow R, Curley S, Vauthey JN, Lynch P, Ellis LM, Wolff R, Lenzi R, Abbruzzese J, Pazdur R, Hoff P, Allen P, Brown T, Skibber J. Improved overall survival among responders to preoperative chemoradiation for locally advanced rectal cancer. Am Jour of Clin Oncol 2001; 24:107-12.
12. MERCURY Study Group. Extramural depth of tumor invasion at thin-section MR in patients with rectal cancer: Results of the MECURY Study. Radiology 2007; 243:132-9.
13. O'Connor OJ, McDermott S, Slattery J, Sahani D, Blake MA. The use of PET-CT in the assessment of patients with colorectal carcinoma. International Journal of Surgical Oncology 2011; 846512
14. Lin M. Molecular imaging using positron emission tomography in colorectal cancer. Discovery Medicine 2012; 69:567-75.
15. Valentini V, Aristei C, Glimelius B, Minsky BD, Beets-Tan B, Borras JM, Haustermans K, Maingon P, Overgaard J, Pahlman L, Quirke P, Schmoll HJ, Sebag-Montefiore D, Taylor I, Van Cutsem E, Van de Velde C, Cellini N, Latini P. Multidisciplinary rectal cancer management: 2nd European Rectal Cancer Consensus Conference (EURECA-CC2). Radiother Oncol 2009; 92:148-63.
16. Glimelius B, Gronberg H, Jarnhult J, Wallgren A, Cavallin-Ståhl E. A systematic overview of radiation therapy effects in rectal cancer. Acta Oncol 2003;42:476-92.
17. Squillaci E, Manenti G, Mancino S, Ciccio C, Calabria F, Danieli R, Schillaci O, Simonetti G. Staging of colon cancer: Whole-body MR vs. whole-body PET-CT-initial clinical experience. Abdom Imaging 2008;33:676-88.
18. Niekel MC, Bipat S, Stoker J. Diagnostic imaging of colorectal liver metastases with CT, MR Imaging, FDG PET and/or FDG PET-CT:A meta-analysis of prospective studies including patients who have not previously undergone treatment. Radiology 2010; 257:674-84.
19. Oken MM, Creech RH, Tormey DC, Horton J, Davis TE, McFadden ET, Carbone PP. Toxicity And Response Criteria Of The Eastern Cooperative Oncology Group. Am J Clin Oncol 1982; 5:649-55.
20. Davey K, Heriot AG, Mackay J, Drummond Belen RB, Estrada Lobato E, Vega Gonzalez IF. Impact of the 18-F-FDG PET/CT on the treatment and management of oncological patients at the National Institute of Cancerology of Mexico. Proceedings of the International Conference on Clinical PET and Molecular Nuclear Medicine, Vienna, Austria, November 8-11, 2011.